The Cooper Companies, Inc. (NASDAQ:COO) Given Average Rating of "Moderate Buy" by Analysts

Key Points

• The Cooper Companies, Inc. (NASDAQ:COO) has received a consensus rating of "Moderate Buy" from twelve analysts, with an average 1-year price target of $86.64.
• Recent broker ratings indicate a wide range of target prices, with reductions from JPMorgan to $66.00 and an upgrade from BNP Paribas to $92.00.
• Insider activity shows a significant increase in ownership, with COO Gerard H. Warner III purchasing 1,450 shares and COO Daniel G. Mcbride acquiring 3,000 shares, bolstering investor confidence in the company.

Shares of The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the twelve ratings firms that are currently covering the stock, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, nine have issued a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $86.6364.

Several analysts have recently weighed in on the stock. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target for the company in a research note on Tuesday, July 22nd. Mizuho decreased their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research note on Wednesday, July 16th. Loop Capital set a $100.00 price target on shares of Cooper Companies in a research note on Tuesday, June 17th. BNP Paribas raised shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, July 22nd. Finally, Robert W. Baird reduced their price objective on shares of Cooper Companies from $97.00 to $85.00 and set an "outperform" rating for the company in a research note on Thursday, August 28th.

Cooper Companies Trading Up 1.4%

Shares of Cooper Companies stock traded up $0.95 on Tuesday, hitting $68.17. 5,454,136 shares of the company traded hands, compared to its average volume of 3,366,609. The stock's 50 day moving average price is $70.66 and its 200-day moving average price is $75.15. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Cooper Companies has a 52 week low of $61.78 and a 52 week high of $111.44. The company has a market cap of $13.55 billion, a PE ratio of 33.58, a PEG ratio of 1.76 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same quarter in the previous year, the firm posted $0.96 earnings per share. The company's revenue was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. Equities research analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Cooper Companies declared that its Board of Directors has approved a share repurchase program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically a sign that the company's leadership believes its stock is undervalued.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride acquired 3,000 shares of Cooper Companies stock in a transaction that occurred on Tuesday, September 2nd. The stock was bought at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the purchase, the chief operating officer directly owned 63,120 shares of the company's stock, valued at approximately $4,105,324.80. This represents a 4.99% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Albert G. White III acquired 10,000 shares of Cooper Companies stock in a transaction that occurred on Friday, September 5th. The stock was acquired at an average cost of $68.39 per share, with a total value of $683,900.00. Following the purchase, the chief executive officer directly owned 226,151 shares of the company's stock, valued at $15,466,466.89. This represents a 4.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 15,975 shares of company stock worth $1,079,566. 1.98% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Cooper Companies

A number of large investors have recently made changes to their positions in the business. Vanguard Group Inc. increased its position in shares of Cooper Companies by 1.8% during the second quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company's stock worth $1,725,963,000 after purchasing an additional 421,423 shares in the last quarter. State Street Corp increased its position in shares of Cooper Companies by 1.2% during the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company's stock worth $616,227,000 after purchasing an additional 104,910 shares in the last quarter. Geode Capital Management LLC increased its position in shares of Cooper Companies by 2.5% during the second quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company's stock worth $368,893,000 after purchasing an additional 127,907 shares in the last quarter. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 3.4% during the first quarter. JPMorgan Chase & Co. now owns 5,177,008 shares of the medical device company's stock worth $436,681,000 after purchasing an additional 172,485 shares in the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company's stock worth $399,340,000 after purchasing an additional 686,751 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.